Form 4: DENTSPLY SIRONA Executive's Stock Vesting Tax Withholding

DENTSPLY SIRONA's SVP, CHRO, Andrea Frohning, had 788 shares withheld to cover taxes related to the vesting of her Restricted Stock Units.

Summary

• Andrea L. Frohning, SVP, CHRO of DENTSPLY SIRONA Inc. (XRAY), reported a transaction on August 8, 2025.
• The transaction involved the disposition of 788 shares of Common Stock at a price of $12.96 per share.
• These shares were withheld to cover tax liabilities associated with the vesting of her Restricted Stock Units (RSUs) and dividend equivalent units.
• Following this transaction, Andrea Frohning beneficially owns 33,252.812 shares of DENTSPLY SIRONA Common Stock.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. The transaction is a routine tax withholding, indicating the vesting of executive equity, which is generally a positive sign of executive retention and alignment. It's not a discretionary sale.

Positives

• The transaction is a routine tax withholding event, indicating the vesting of previously granted equity awards to a senior executive.
• Vesting of RSUs suggests the executive is meeting performance or tenure requirements, aligning management interests with shareholders.

Negatives

• The disposition of shares, even for tax purposes, slightly reduces the executive's direct ownership.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing.

Industry Context

This is a routine insider transaction filing, common across all industries when executive equity awards vest. It does not provide specific industry context or competitive insights.

Comparison to Industry Standards

• This is a standard Form 4 filing for Restricted Stock Unit (RSU) vesting and tax withholding, which is a common practice for executive compensation across publicly traded companies in various sectors, including healthcare and dental equipment manufacturing.
• The mechanism of withholding shares to cover tax liabilities upon RSU vesting is a widely adopted and compliant method for managing executive equity compensation, consistent with practices observed in companies like Johnson & Johnson (JNJ) or Medtronic (MDT) when their executives' equity awards vest.

Stakeholder Impact

• Shareholders: Minimal direct impact. It is a routine transaction related to executive compensation. The executive's continued beneficial ownership aligns interests.
• Employees: No direct impact mentioned.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary transaction where shares were withheld for tax purposes upon the vesting of Restricted Stock Units. This is a standard part of executive compensation and does not indicate any change in the company's fundamentals, strategic direction, or the executive's confidence in the company. Therefore, it provides no new information that would warrant a change in investment recommendation. Investors should continue to hold based on broader company performance and market conditions.

Keywords

DENTSPLY SIRONA, XRAY, Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Tax Withholding, Executive Compensation, Andrea Frohning